Efficacy and Safety of SGLT-2 Inhibitors in Patients with Uncontrolled or Resistant Hypertension: A Pilot Meta-Analysis of Randomized Clinical Trials.
SGLT-2 inhibitors provide a modest incremental benefit in lowering office systolic blood pressure for patients with uncontrolled or resistant hypertension on multidrug regimens with an overall acceptable safety profile.